DalCor Pharma and Canada’s unsung life-sciences boom

While high-profile software financings in Canada have recently grabbed headlines, a major surge of investment in life sciences startups has mostly gone unnoticed. Fueled by improved fundraising and exit trends, venture investment in biotech, pharmaceuticals, medical diagnostics and other life sciences sectors has gained traction since 2010. Dollar flows more than doubled over this period, reaching $523 million invested in 2015. That’s the largest VC deployment to life sciences in nearly a decade.

FeaturedCanadaNorth AmericaFeaturedBriefs